EMEA-001438-PIP01-13-M01
Key facts
| Invented name |
Praxbind
|
| Active substance |
idarucizumab
|
| Therapeutic area |
Other
|
| Decision number |
P/0151/2019
|
| PIP number |
EMEA-001438-PIP01-13-M01
|
| Pharmaceutical form(s) |
Solution for injection/infusion
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Boehringer Ingelheim International GmbH
Tel. +49 6132 778271 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-001438-PIP01-13-M01
|
| Compliance opinion date |
24/07/2020
|
| Compliance outcome |
positive
|